Page info
title title

• Patlak M, Balogh E, & Nass S (2012) Facilitating Collaborations to Develop Combination Investigational Cancer Therapies. National Cancer Policy Forum.

• Jeon Y, Xun Z, Su P, & Rogers P (2012) Genome-wide transcriptomic analysis of a flocculent strain of Zymomonas mobilis. Applied Microbiology and Biotechnology:1-6.

• Lembo A, Di Cunto F, & Provero P (2012) Shortening of 3UTRs Correlates with Poor Prognosis in Breast and Lung Cancer. Plos One 7(2):e31129.

• Lockwood WW, et al. (2012) Integrative Genomics Identified RFC3 as an Amplified Candidate Oncogene in Esophageal Adenocarcinoma. Clinical Cancer Research.

• Lu Y, Wang L, Liu P, Yang P, & You M (2012) Gene-Expression Signature Predicts Postoperative Recurrence in Stage I Non-Small Cell Lung Cancer Patients. Plos One 7(1):e30880.

• Tseng GC, Ghosh D, & Feingold E (2012) Comprehensive literature review and statistical considerations for microarray meta-analysis. Nucleic Acids Research.

• Imielinski M, et al. (2012) Integrated proteomic, transcriptomic, and biological network analysis of breast carcinoma reveals molecular features of tumorigenesis and clinical relapse. Molecular & Cellular Proteomics.

...

• Onaitis M, et al. (2011) A 10-Gene Progenitor Cell Signature Predicts Poor Prognosis in Lung Adenocarcinoma. The Annals of Thoracic Surgery 91(4):1046-1050.unmigrated-wiki-markup

• Meng X, et al. (2011) GSI-I (Z-LLNle-CHO) inhibits \ [gamma\]-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia. Leukemia 25(7):1135-1146.

• Kadara H, et al. (2011) A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis. Clinical Cancer Research 17(6):1490-1501.

...